首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1667687

2025 年全球藥物塗層球囊市場

Drug-Coated Balloons Global Market Report 2025

出版日期: 2025年02月28日 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年藥物塗層球囊市場將快速成長。預計到 2029 年將以 15.6% 的複合年成長率成長，達到 22.2 億美元。

預測期內成長的主要驅動力包括老年人口的成長、適應症和用途的擴大、對門診和門診護理的關注度增加、與藥物輸送創新的結合以及全球健康舉措。預測期內的關鍵趨勢包括新配方的監管核准、注重減少副作用、生物可吸收塗層的出現、新興國家的市場擴張以及以患者為中心的方法。

冠狀動脈疾病（CAD）盛行率的不斷上升預計將在未來幾年推動藥物塗層球囊市場的成長。藥物塗層球囊是用於治療 CAD 的醫療設備，可在手術過程中將藥物釋放到動脈中，以防止再狹窄（血管成形術後動脈血管再阻塞）。根據 2022 年 8 月發表在《美國心臟病學會雜誌》上的一項研究，預計 2025 年至 2060 年期間美國普通人群的所有四種心血管風險因素都將增加。預測增幅最大的是糖尿病，為39.3%；其次為血脂異常症，為27.6%；高血壓，為25.1%；肥胖，為18.3%。此外，心臟衰竭（33.4%）和缺血性心臟疾病（30.7%）的發病率預計將增加最大，心肌梗塞（16.9%）和中風（33.8%）的發生率也將增加最大。由於這些因素，CAD 盛行率的上升預計將推動藥物塗層球囊市場的發展。

門診手術中心的增加預計也將推動藥物塗層球囊市場的成長。門診手術中心 (ASC) 是專門執行無需住院過夜的手術的醫療機構。藥物塗層球囊在 ASC 中發揮重要作用，因為與標準球囊相比，它們可以縮短手術時間。 2023 年 9 月，VMG Health 報告稱，經 Medicare 認證的門診手術中心總數將從 2021 年的 1,752 家增加 2.9% 至 2022 年的 1,804 家。基於這些原因，門診手術中心的日益普及也推動了藥物塗層球囊市場的擴大。

本報告調查了全球藥物塗層球囊市場，並總結了市場概況和特點、主要趨勢、市場影響因素分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局以及主要企業的概況。

市場規模趨勢與預測：按產品
用於治療周邊動脈疾病的藥物塗層球囊
用於 CAD 的藥物塗層球囊
藥物塗層球囊的其他適應症
市場規模趨勢及預測：依藥物類型
紫杉醇
Sirolimus
市場規模趨勢與預測：按最終用戶
醫院
心導管實驗室
門診手術中心
市場規模趨勢與預測：周邊動脈疾病藥物塗層球囊依亞型分類
紫杉醇塗層球囊
Sirolimus塗層球囊
市場規模趨勢與預測：CAD 藥物塗層球囊依亞型分類
紫杉醇塗層球囊
Sirolimus塗層球囊
Everolimus塗層球囊
市場規模趨勢及預測：其他適應症藥物塗層球囊依亞型分類
藥物塗層球囊治療股膕動脈損傷
用於治療腎動脈病變的藥物塗層球囊
用於其他血管應用的藥物塗層球囊

7. 藥物塗層球囊市場：區域與國家分析

市場規模趨勢與預測：按地區
市場規模趨勢與預測：依國家

8. 亞太地區藥物塗層球囊市場

9. 中國藥物塗層球囊市場

第10章印度藥物塗層氣球市場

第11章日本藥物塗層球囊市場

12. 澳洲藥物塗層球囊市場

13. 印尼藥物塗層球囊市場

第14章韓國藥物塗裝球囊市場

15.西歐藥物塗層球囊市場

第16章英國藥物塗層球囊市場

17. 德國藥物塗層球囊市場

18. 法國藥物塗層球囊市場

19. 義大利藥物塗層氣球市場

20.西班牙藥用塗層球囊市場

21. 東歐藥物塗層球囊市場

22. 俄羅斯藥物塗層氣球市場

23. 北美藥物塗層球囊市場

第24章美國藥物塗層球囊市場

25. 加拿大藥物塗層球囊市場

26.南美洲藥物塗層氣球市場

27. 巴西藥物塗層球囊市場

28. 中東藥物塗層氣球市場

29. 非洲藥物塗層氣球市場

第 30 章藥物塗層球囊市場：競爭格局與公司概況

競爭格局
公司簡介
- Acotec Scientific AG
- B. Braun Melsungen AG
- Biosensors International Group Ltd
- Medtronic Inc.
- Boston Scientific Corporation

第 31 章藥物塗層球囊市場：其他領先與創新企業

Opto Circuits
Concept Medical
Cardionovum GmbH
Endocor GmbH
Hexacath Sverige
iVascular SLU
Minvasys SAS
MedAlliance
QT Vascular Ltd
Terumo Corporation
Biotronik
Cook Medical
Cordis Corporation
Abbott Laboratories
Surmodics Inc.

第 32 章全球藥物塗層球囊市場：競爭基準化分析與儀表板

第 33 章藥物塗層球囊市場：主要併購

第 34 章藥物塗層球囊市場：最新趨勢

第 35 章藥物塗層球囊市場：潛在國家、細分市場與策略

提供最多新機會的國家
提供最新機會的市場區隔
成長策略

第 36 章附錄

簡介目錄

Product Code: r24098

A drug-coated balloon (DCB) is a medical device employed in the intervention of narrowed or obstructed blood vessels, particularly in interventional cardiology and interventional radiology. Its design facilitates the direct delivery of medication to the site of vascular disease while concurrently performing angioplasty.

The primary categories of products encompassed within drug-coated balloons include those tailored for peripheral artery disease, coronary artery disease, and other indications. Drug-coated balloons (DCBs) for peripheral artery disease are a specific type of medical device utilized in addressing peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of blood vessels outside the heart or in the lower extremities. Various drug types, such as paclitaxel and sirolimus, are employed, and the end-users encompass hospitals, cardiac catheterization labs, and ambulatory surgical centers.

The drug-coated balloons market research report is one of a series of new reports from The Business Research Company that provides drug-coated balloons market statistics, including drug-coated balloons industry global market size, regional shares, competitors with a drug-coated balloons market share, detailed drug-coated balloons market segments, market trends and opportunities, and any further data you may need to thrive in the drug-coated balloons industry. This drug-coated balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug-coated balloons market size has grown rapidly in recent years. It will grow from$1.08 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches.

The increasing prevalence of coronary artery disease (CAD) is projected to drive the growth of the drug-coated balloons market in the future. CAD is a medical condition characterized by the narrowing or blockage of the coronary arteries that supply blood to the heart muscle, often leading to heart attacks. Drug-coated balloons are medical devices used to treat coronary artery disease, releasing medication into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery following angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are expected to rise among the general U.S. population from 2025 to 2060. Diabetes is projected to see the most significant increase at 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. Additionally, the researchers found that rates of heart failure (33.4%) and ischemic heart disease (30.7%) are expected to experience the largest increases, along with heart attacks (16.9%) and strokes (33.8%). Consequently, the rise in coronary artery disease prevalence is anticipated to boost the drug-coated balloon market.

The increasing number of ambulatory surgery centers is anticipated to propel the growth of the drug-coated balloon market. Ambulatory Surgical Centers (ASCs) are medical facilities dedicated to conducting surgical procedures that do not necessitate an overnight hospital stay. Drug-coated balloons play a crucial role in ASCs by offering shorter procedure times compared to standard balloons, resulting in improved patient throughput and reduced operational costs. For instance, VMG Health reported in September 2023 that the total number of Medicare-certified ambulatory surgery centers increased by 2.9% from 1752 in 2021 to 1804 in 2022. Hence, the growing prevalence of ambulatory surgery centers is a driving force behind the drug-coated balloon market's expansion.

Product innovations are emerging as a significant trend in the drug-coated balloon market. Leading companies in this sector are concentrating on developing new technological and innovative solutions to enhance their market position. For example, in August 2022, Becton, Dickinson, and Company (BD), a U.S.-based medical technology firm, initiated the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). This trial is designed to evaluate the safety and effectiveness of the sirolimus DCB for treating patients with peripheral artery disease, a condition that greatly affects mobility and quality of life.

Leading companies in the drug-coated balloon sector are dedicated to advancing their technologies, including paclitaxel-coated balloon catheters, to improve treatment efficacy for conditions such as coronary in-stent restenosis. These advancements aim to enhance patient outcomes and minimize the risk of complications associated with traditional therapies. Paclitaxel-coated balloon catheters are specialized devices that release the drug paclitaxel into the artery wall upon inflation, helping to prevent re-narrowing after angioplasty. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based medical device manufacturer, received approval from the U.S. Food and Drug Administration (FDA) for its AGENT(TM) Drug-Coated Balloon (DCB). This device is designed specifically for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease, which occurs when a previously stented blood vessel becomes obstructed or narrowed due to plaque or scar tissue.

In November 2022, Cordis, a US-based manufacturer of interventional cardiovascular technologies, completed the acquisition of Med Alliance SA for $1.1 billion. Through this acquisition, Cordis aims to globally provide the drug-eluting balloon SELUTION SLRTM (Sustained Limus Release) to two million patients by 2027. Med Alliance SA, based in Switzerland, is a developer of the sirolimus micro-reservoir drug-coated balloon.

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug-coated balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-coated balloons market consists of sales of everolimus and zotarolimus drug-coated balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug-Coated Balloons Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug-coated balloons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug-coated balloons ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug-coated balloons market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Drug-Coated Balloons For Peripheral Artery Disease; Drug-Coated Balloons For Coronary Artery Disease; Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel; Sirolimus
3) By End User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers
Subsegments:
1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons
2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons; Everolimus-Coated Balloons
3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions; Drug-Coated Balloons For Renal Artery Lesions; Drug-Coated Balloons For Other Vascular Applications
Companies Mentioned: Acotec Scientific AG; B. Braun Melsungen AG; Biosensors International Group Ltd; Medtronic Inc.; Boston Scientific Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Drug-Coated Balloons Market Characteristics

3. Drug-Coated Balloons Market Trends And Strategies

4. Drug-Coated Balloons Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Drug-Coated Balloons Growth Analysis And Strategic Analysis Framework

5.1. Global Drug-Coated Balloons PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Drug-Coated Balloons Market Growth Rate Analysis
5.4. Global Drug-Coated Balloons Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Drug-Coated Balloons Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Drug-Coated Balloons Total Addressable Market (TAM)

6. Drug-Coated Balloons Market Segmentation

6.1. Global Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-Coated Balloons For Peripheral Artery Disease
Drug-Coated Balloons For Coronary Artery Disease
Drug-Coated Balloons For Other Indications
6.2. Global Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Paclitaxel
Sirolimus
6.3. Global Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cardiac Catheterization Labs
Ambulatory Surgical Centers
6.4. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Peripheral Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Paclitaxel-Coated Balloons
Sirolimus-Coated Balloons
6.5. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Paclitaxel-Coated Balloons
Sirolimus-Coated Balloons
Everolimus-Coated Balloons
6.6. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-Coated Balloons For Femoropopliteal Lesions
Drug-Coated Balloons For Renal Artery Lesions
Drug-Coated Balloons For Other Vascular Applications

7. Drug-Coated Balloons Market Regional And Country Analysis

7.1. Global Drug-Coated Balloons Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug-Coated Balloons Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug-Coated Balloons Market

8.1. Asia-Pacific Drug-Coated Balloons Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug-Coated Balloons Market

9.1. China Drug-Coated Balloons Market Overview
9.2. China Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug-Coated Balloons Market

10.1. India Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug-Coated Balloons Market

11.1. Japan Drug-Coated Balloons Market Overview
11.2. Japan Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug-Coated Balloons Market

12.1. Australia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug-Coated Balloons Market

13.1. Indonesia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug-Coated Balloons Market

14.1. South Korea Drug-Coated Balloons Market Overview
14.2. South Korea Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug-Coated Balloons Market

15.1. Western Europe Drug-Coated Balloons Market Overview
15.2. Western Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug-Coated Balloons Market

16.1. UK Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug-Coated Balloons Market

17.1. Germany Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug-Coated Balloons Market

18.1. France Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug-Coated Balloons Market

19.1. Italy Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug-Coated Balloons Market

20.1. Spain Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug-Coated Balloons Market

21.1. Eastern Europe Drug-Coated Balloons Market Overview
21.2. Eastern Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug-Coated Balloons Market

22.1. Russia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug-Coated Balloons Market

23.1. North America Drug-Coated Balloons Market Overview
23.2. North America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug-Coated Balloons Market

24.1. USA Drug-Coated Balloons Market Overview
24.2. USA Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug-Coated Balloons Market

25.1. Canada Drug-Coated Balloons Market Overview
25.2. Canada Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug-Coated Balloons Market

26.1. South America Drug-Coated Balloons Market Overview
26.2. South America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug-Coated Balloons Market

27.1. Brazil Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug-Coated Balloons Market

28.1. Middle East Drug-Coated Balloons Market Overview
28.2. Middle East Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug-Coated Balloons Market

29.1. Africa Drug-Coated Balloons Market Overview
29.2. Africa Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug-Coated Balloons Market Competitive Landscape And Company Profiles

30.1. Drug-Coated Balloons Market Competitive Landscape
30.2. Drug-Coated Balloons Market Company Profiles
- 30.2.1. Acotec Scientific AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Biosensors International Group Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug-Coated Balloons Market Other Major And Innovative Companies

31.1. Opto Circuits
31.2. Concept Medical
31.3. Cardionovum GmbH
31.4. Endocor GmbH
31.5. Hexacath Sverige
31.6. iVascular SLU
31.7. Minvasys SAS
31.8. MedAlliance
31.9. QT Vascular Ltd
31.10. Terumo Corporation
31.11. Biotronik
31.12. Cook Medical
31.13. Cordis Corporation
31.14. Abbott Laboratories
31.15. Surmodics Inc.

32. Global Drug-Coated Balloons Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug-Coated Balloons Market

34. Recent Developments In The Drug-Coated Balloons Market

35. Drug-Coated Balloons Market High Potential Countries, Segments and Strategies

35.1 Drug-Coated Balloons Market In 2029 - Countries Offering Most New Opportunities
35.2 Drug-Coated Balloons Market In 2029 - Segments Offering Most New Opportunities
35.3 Drug-Coated Balloons Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies